Oncology News

Oncology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Banelli B et al. – Quantitative methylation is a promising tool to predict survival in neuroblastic tumor patients. The results lead to the hypothesis that a subset of patients considered at high risk – but displaying low levels of methylation – could be assigned at a lower risk group.


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address